Pulmonx Corporation (LUNG) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 4 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for LUNG is $4.00, representing a +166.7% upside from the current price of $1.5. Price targets range from a low of $4.00 to a high of $4.00.
